Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
The epilogue
December 10, 2024
A final message from ACP’s retiring registrar Greg Eberhart.
Read more ➞